Tc Biopharm Plc Stock Market Value
| TCBPW Stock | USD 0.02 0.0005 3.03% |
| Symbol | TCBPW |
TC BioPharm plc Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of TC BioPharm. If investors know TCBPW will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about TC BioPharm listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.87) | Earnings Share (0.75) | Revenue Per Share 29.639 | Return On Assets (1.09) | Return On Equity (12.17) |
The market value of TC BioPharm plc is measured differently than its book value, which is the value of TCBPW that is recorded on the company's balance sheet. Investors also form their own opinion of TC BioPharm's value that differs from its market value or its book value, called intrinsic value, which is TC BioPharm's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because TC BioPharm's market value can be influenced by many factors that don't directly affect TC BioPharm's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between TC BioPharm's value and its price as these two are different measures arrived at by different means. Investors typically determine if TC BioPharm is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, TC BioPharm's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
TC BioPharm 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to TC BioPharm's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of TC BioPharm.
| 10/26/2024 |
| 11/25/2024 |
If you would invest 0.00 in TC BioPharm on October 26, 2024 and sell it all today you would earn a total of 0.00 from holding TC BioPharm plc or generate 0.0% return on investment in TC BioPharm over 30 days. TC BioPharm is related to or competes with BioAffinity Technologies, Alvotech Warrant, and Inspira Technologies. TC Biopharm Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its a... More
TC BioPharm Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure TC BioPharm's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess TC BioPharm plc upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 22.83 | |||
| Information Ratio | 0.1886 | |||
| Maximum Drawdown | 123.93 | |||
| Value At Risk | (33.78) | |||
| Potential Upside | 57.94 |
TC BioPharm Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for TC BioPharm's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as TC BioPharm's standard deviation. In reality, there are many statistical measures that can use TC BioPharm historical prices to predict the future TC BioPharm's volatility.| Risk Adjusted Performance | 0.1578 | |||
| Jensen Alpha | 5.39 | |||
| Total Risk Alpha | 1.04 | |||
| Sortino Ratio | 0.2427 | |||
| Treynor Ratio | 2.52 |
TC BioPharm plc Backtested Returns
TC BioPharm is out of control given 3 months investment horizon. TC BioPharm plc retains Efficiency (Sharpe Ratio) of 0.16, which indicates the company had a 0.16% return per unit of price deviation over the last 3 months. We were able to interpolate data for thirty different technical indicators, which can help you to evaluate if expected returns of 4.62% are justified by taking the suggested risk. Use TC BioPharm plc market risk adjusted performance of 2.53, and Standard Deviation of 29.37 to evaluate company specific risk that cannot be diversified away. TC BioPharm holds a performance score of 12 on a scale of zero to a hundred. The firm owns a Beta (Systematic Risk) of 2.25, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, TC BioPharm will likely underperform. Use TC BioPharm plc standard deviation and the relationship between the value at risk and market facilitation index , to analyze future returns on TC BioPharm plc.
Auto-correlation | -0.25 |
Weak reverse predictability
TC BioPharm plc has weak reverse predictability. Overlapping area represents the amount of predictability between TC BioPharm time series from 26th of October 2024 to 10th of November 2024 and 10th of November 2024 to 25th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of TC BioPharm plc price movement. The serial correlation of -0.25 indicates that over 25.0% of current TC BioPharm price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.25 | |
| Spearman Rank Test | -0.15 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
TC BioPharm plc lagged returns against current returns
Autocorrelation, which is TC BioPharm stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting TC BioPharm's stock expected returns. We can calculate the autocorrelation of TC BioPharm returns to help us make a trade decision. For example, suppose you find that TC BioPharm has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
TC BioPharm regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If TC BioPharm stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if TC BioPharm stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in TC BioPharm stock over time.
Current vs Lagged Prices |
| Timeline |
TC BioPharm Lagged Returns
When evaluating TC BioPharm's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of TC BioPharm stock have on its future price. TC BioPharm autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, TC BioPharm autocorrelation shows the relationship between TC BioPharm stock current value and its past values and can show if there is a momentum factor associated with investing in TC BioPharm plc.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for TCBPW Stock Analysis
When running TC BioPharm's price analysis, check to measure TC BioPharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TC BioPharm is operating at the current time. Most of TC BioPharm's value examination focuses on studying past and present price action to predict the probability of TC BioPharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TC BioPharm's price. Additionally, you may evaluate how the addition of TC BioPharm to your portfolios can decrease your overall portfolio volatility.